Note: You clicked on an external link, which has been disabled in order to keep your shopping session open.
|Tested species reactivity||Human|
|Host / Isotype||Mouse / IgG1|
|Immunogen||White blood cells.|
|Conjugate||FITC , PE|
|Storage buffer||PBS with 0.2% carrier protein|
|Contains||0.08% sodium azide|
|Storage Conditions||4° C, do not freeze|
|Tested Applications||Dilution *|
|Flow Cytometry (Flow)||Assay Dependent|
* Suggested working dilutions are given as a guide only. It is recommended that the user titrate the product for use in their own experiment using appropriate negative and positive controls.
This antibody is a monoclonal mixture of FITC-conjugated CD10 (clone RXB.14, isotype IgG1) and PE-conjugated CD19 (clone 1G9, isotype IgG1).
Anti-hCD10 recognizes a human common acute lymphoblastic antigen (CALLA), MW 100 kDa. The CD10 antigen is identical to human membrane-associated neutral endopeptidase (NEP;EC 220.127.116.11), also known as enkephalinase. The CD10 antigen is found on lymphocytes from patients with acute B-lymphoid leukemia. The antigen is also present on a wide variety of normal and neoplastic cell types including renal epithellum, fibroblasts, granulocytes and some lymphoma, melanoma and glioma cell lines. Identification of CD19 PE human B cells associated approximately 10% of peripheral blood lymphocytes expressing the 95,000 M.W. surface antigen.
For Research Use Only. Not for use in diagnostic procedures. Not for resale without express authorization.
atriopeptidase; AW495831; B-lymphocyte surface antigen B4; CALLA; CD10; common acute lymphocytic leukemia antigen; differentiation antigen CD19; enkephalinase; membrane metallo-endopeptidase; membrane metallo-endopeptidase (neutral endopeptidase, enkephalinase, CALLA, CD10); membrane metallo-endopeptidase neutral endopeptidase; membrane metallo-endopeptidase variant 1; membrane metallo-endopeptidase variant 2; NEP; neprilysin-390; neprilysin-411; neutral endopeptidase 24.11; SFE; skin fibroblast elastase; T-cell surface antigen Leu-12
B4; CALLA; CD10; CD19; CMT2T; CVID3; EPN; MME; NEP; SFE